Cardiothoracic & vascular anesthesia

Negative extra-abdominal pressure (NEXAP)-based lung recruitment maneuver versus standard lung recruitment maneuver in the treatment of postoperative atelectasis after cardiac surgery: A single-center randomized controlled trial

J Crit CarePublished Randomised controlled trial

Authors' conclusion

NEXAP is an effective treatment for atelectasis after cardiac surgery, which significantly reduced patients' LUSS, improved pulmonary ventilation (especially in the lateral and posterior regions). NEXAP can further reduce LUSStot than the traditional PEEP-based LRM.

Study context

Population
Patients with atelectasis after cardiac surgery
Participants
29 vs 33
Comparison
NEXAP-based lung recruitment maneuver (LRM) vs stepwise positive end-expiratory pressure (PEEP)-based LRM
  • NEXAPn = 29
  • PEEPn = 33reference
Primary endpoint
Lung ultrasound score (LUSS), global (LUSStot) and regional (posterior, anterior, lateral)
Methodological detailssingle-centre
  • Single-centre

Primary result

As reported in the abstract

Change in LUSStot after LRM (ΔLUSStot)
GroupValueLUSStot before vs after LRM
NEXAP−5.1 (SD 2.3)20.7 ± 3.2 vs. 15.6 ± 3.3; p < 0.001
PEEP−3.8 (SD 2.2)21.5 ± 4.2 vs. 17.1 ± 4.6; p < 0.001

Value

NEXAP−5.1 (SD 2.3)
PEEP−3.8 (SD 2.2)

LUSStot before vs after LRM

NEXAP20.7 ± 3.2 vs. 15.6 ± 3.3; p < 0.001
PEEP21.5 ± 4.2 vs. 17.1 ± 4.6; p < 0.001
  • NEXAP vs PEEP: P = 0.020 — ΔLUSStot significantly greater with NEXAP

Further findings

PaO2/FiO2, PaO2, Vt and Crs

Significantly improved in both groups

Original publication

Negative extra-abdominal pressure (NEXAP)-based lung recruitment maneuver versus standard lung recruitment maneuver in the treatment of postoperative atelectasis after cardiac surgery: A single-center randomized controlled trial. J Crit Care. Published 22 May 2025. doi:10.1016/j.jcrc.2025.155124

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.